FUNDAMENTALS · Fundamentals · TW Healthcare

Formosa Optical Technology (5312) Fundamentals 2026 — P/E 15.6x, Revenue Analysis | SniperIQ

Formosa Optical Technology (5312) is a TW-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of NT$5.5B, trading at NT$91.60 on the TWO. This SniperIQ fundamentals page covers Formosa Optical Technology's valuation (P/E 15.6x, P/B 1.4x), profitability (net margin 8.3%), revenue (NT$4.1B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market CapNT$5.5B
P/E (TTM)15.6x
Net Margin8.3%
Revenue (FY25)NT$4.1B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Formosa Optical Technology's market cap?

Formosa Optical Technology (5312) has a market capitalization of approximately NT$5.5B, trading at NT$91.60 on the TWO. Market cap moves with the live share price.

What is Formosa Optical Technology's P/E ratio?

Formosa Optical Technology's trailing twelve-month P/E ratio is 15.6x, with a price-to-book (P/B) of 1.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Formosa Optical Technology?

Formosa Optical Technology runs a net profit margin of 8.3%, a gross margin of 63.7%, and an operating margin of 7.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Formosa Optical Technology generate?

Formosa Optical Technology reported revenue of NT$4.1B for fiscal year 2025, with net income of NT

85M and earnings per share (EPS) of 6.41. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Formosa Optical Technology pay a dividend?

Formosa Optical Technology offers a trailing dividend yield of about 7.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Formosa Optical Technology financially healthy?

Formosa Optical Technology carries a debt-to-equity ratio of 0.87x and a current ratio of 1.60x, with a market beta of 0.01. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Formosa Optical Technology a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Formosa Optical Technology (5312) the key facts are: market cap NT$5.5B, P/E 15.6x, revenue NT$4.1B, 52-week range 87-138.5. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Formosa Optical Technology's full fundamentals live

Get Formosa Optical Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.